Hims & Hers Health is revolutionizing telehealth with a vertically integrated model, offering personalized medications and achieving rapid subscription growth, driving long-term profitability and ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our P/B Growth Investor model based on the published ...

1 Day HIMS 1.54% DJIA -0.82% S&P 500 -0.59% Retail/Wholesale 0.40% ...

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Analyst Allen Lutz of Bank of America Securities maintained a Sell rating on Hims & Hers Health (HIMS – Research Report), retaining the price target of $18.00. Discover top-rated stocks from ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

1 Day HIMS 1.99% DJIA 0.91% S&P 500 1.10% Retail/Wholesale 1.30% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

View Hims & Hers Health, Inc. (HIMS) current and estimated P/E ratio data provided by Seeking Alpha.